News
Ten Mayo men were part of the AbbVie squad that captured the All-Ireland Intermediate Interfirms title, defeating Boston ...
AbbVie’s stock has analysts in a polite disagreement—some say “buy,” others say “meh,” but no one’s yelling “sell.” The ...
Shares of AbbVie Inc. ABBV slipped 1.64% to $170.16 Monday, on what proved to be an all-around dismal trading session for the ...
Class will soon be in session at Allergan Aesthetics.Allergan Medical Institute (AMI), the educational arm of Allergan, is ...
Collaboration aims to leverage the ISPOR UAE Chapter’s network and knowledge in HEOR and AbbVie’s scientific expertise to ...
We recently published a list of Jim Cramer’s Game Plan for Next Week: 25 Stocks in Focus. In this article, we are going to ...
Abbvie (Sligo) won their first ever All-Ireland Inter-Firms title after defeating Boston Scientific (Cork) 1-11 to 1-6 in the All-Ireland Intermediate Football Final last Friday evening in Bishopstown ...
US drug maker AbbVie has launched its key leukemia drug, Venetoclax, in India, marking its entry into the country's oncology ...
AbbVie expands global oncology footprint in India with launch of Venetoclax: Our Bureau, Bengaluru Monday, April 21, 2025, 16:40 Hrs [IST] AbbVie, a global biopharmaceutical major ...
BofA lowered the firm’s price target on AbbVie (ABBV) to $200 from $223 and keeps a Neutral rating on the shares. The firm updated estimates ...
Discover a 6-fund ETF portfolio targeting 6% yield for $5,000 monthly income on $1M. Achieve diversification, growth, and ...
The Vanguard Value ETF is an index fund, tracking the CRSP US Large Cap Value Index, which itself is focused on holding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results